National Institutes of Health: Autism Spectrum Disorder trials

The registry lists 22 Autism Spectrum Disorder studies with National Institutes of Health as lead sponsor. 4 are open to participants now and 2 have results posted.

Phase 1 2Phase 2 5No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Characterization of Dysmorphology in Subjects With Creatine Transporter DeficiencyRecruitingNCT05600946
• Role of GABAergic Transmission in Auditory Processing in Autism Spectrum DisorderRecruitingNCT04798274Not applicable
• Developing Brain, Impulsivity and CompulsivityRecruitingNCT04631042
• The Neurodevelopmental and Behavioral Phenotyping Screening ProtocolRecruitingNCT00271622
• A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With AutismTerminatedNCT01887132Phase 2Results posted
• Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum DisordersCompletedNCT00251303Phase 2Results posted
• Pediatric Patients With Metabolic or Other Genetic DisordersCompletedNCT02769949
• Near Infrared Spectroscopy in Children With Autism and ADHDTerminatedNCT01730079
• A Study of the Association Between Autism and Immune Changes in the BrainTerminatedNCT01322555
• A Study of Divalproex Sodium in Children With ASD and Epileptiform EEGWithdrawnNCT01170325Phase 2
• A Coping Effectiveness Training Intervention for Caregivers of Children With Autism Spectrum: A Feasibility StudyCompletedNCT01168284Not applicable
• Brain Imaging Study of Adults With Autism Spectrum DisordersCompletedNCT01093768Phase 1
• Exome Sequencing in Autistic Spectrum DisorderCompletedNCT01059201
• Cognitive Neuroscience of Autism Spectrum DisordersCompletedNCT01031407
• A Magnetic Resonance Spectroscopic Examination of Children and Adolescents Taking Riluzole for Obsessive-Compulsive DisorderTerminatedNCT01019967
• Optimizing Social and Communication Outcomes for Toddlers With AutismCompletedNCT00999778Not applicable
• Cholesterol in ASD: Characterization and TreatmentCompletedNCT00965068Phase 1/2
• Identification of Characteristics Associated With Symptom Remission in AutismCompletedNCT00938054
• Predictors of Caregiver Adaptation to Pervasive Developmental DisordersCompletedNCT00496210
• Mercury Chelation to Treat AutismWithdrawnNCT00376194Phase 2
• Clinical and Immunological Investigations of Subtypes of AutismCompletedNCT00298246
• Methylphenidate in Children and Adolescents With Pervasive Developmental DisordersCompletedNCT00025779Not applicable